Ruxolitinib

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 9 USDMF, 2 EU WC, 1 KDMF, 17 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

60 Drugs in Development

60 Drugs in Development

INTERMEDIATES

21 Intermediates Suppliers

21 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 6 FDA Orange Book, 7 Europe, 18 Australia, 3 South Africa, 9 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 10 Microlex e.U, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 9 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 24 Direct Compression, 16 Disintegrants & Superdisintegrants, 14 Granulation, 13 Thickeners and Stabilizers, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 7 Solubilizers, 7 Controlled & Modified Release, 3 Emulsifying Agents, 3 Coating Systems & Additives, 3 Parenteral, 2 Film Formers & Plasticizers, 2 Taste Masking, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Rheology Modifiers